Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X/Twitter:
“Circulating tumor DNA (ctDNA) testing before radical cystectomy can predict disease recurrence and advanced pathology in Bladder Cancer patients.
This research suggests ctDNA could revolutionize pre-surgical decision-making and treatment strategies, ensuring more personalized care.”
View additional information.
Source: Yüksel Ürün/X